However, while both medications have similar side effect profiles, serious side effects may vary between the two and must be considered with the help of your doctor and regarding your personal situation
Autism 12 , 68
FDA has released its briefing materials for the meeting, published its current position on the substances under review, updated the meeting schedule, and announced that another peptide-focused PCAC meeting will take place before the end of February 2027
Bonaccio M, Di Castelnuovo A, Costanzo S, Gialluisi A, Persichillo M, Cerletti C, et al
Because of the safety concerns and lack of approval, it should be approached with caution and medical guidance